Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X 
WOBURN, Mass., March 14, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its fourth quarter 2016 financial results and host a conference call with management after market close on Wednesday, March 22, 2017.
Shareholders will participate in the call in listen-only mode. The Company invites shareholders to submit questions for consideration by March 17, 2017 to [email protected] with the subject line: “Questions for Year-end Call.” Questions submitted in advance of the call will be reviewed and some will be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Wednesday, March 22 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com. The webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial 877-660-6853 (toll-free) or 201-612-7415 (international) and enter passcode 13654728. The replay will be available for 14 days.
About Yield10
Yield10 Bioscience, Inc. is focused on developing disruptive technologies for producing step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA. For more information about the Company, please visit www.yield10bio.com. (YTEN-E)
Yield10 Inquiries: Lynne H. Brum, (617) 682-4693, [email protected] Investor Relations Contact: Amato and Partners, LLC 90 Park Avenue, 17th Floor New York, NY 10016 [email protected]
